Literature DB >> 29030341

Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.

Cesar A Meschiari1, Mira Jung1, Rugmani Padmanabhan Iyer1, Andriy Yabluchanskiy2, Hiroe Toba1,3, Michael R Garrett4, Merry L Lindsey1,5.   

Abstract

Matrix metalloproteinase (MMP)-9 increases in the myocardium with advanced age and after myocardial infarction (MI). Because young transgenic (TG) mice overexpressing human MMP-9 only in macrophages show better outcomes post-MI, whereas aged TG mice show a worse aging phenotype, we wanted to evaluate the effect of aging superimposed on MI to see if the detrimental effect of aging counteracted the benefits of macrophage MMP-9 overexpression. We used 17- to 28-mo-old male and female C57BL/6J wild-type (WT) and TG mice ( n = 10-21 mice/group) to evaluate the effects of aging superimposed on MI. Despite similar infarct areas and mortality rates at day 7 post-MI, aging TG mice showed improved diastolic properties and remodeling index compared with WT mice (both P < 0.05). Macrophage numbers were higher in TG than WT mice at days 0 and 7 post-MI, and the post-MI increase was due to elevated cluster of differentiation 18 protein levels (all P < 0.05). RNA sequencing analysis of cardiac macrophages isolated from day 7 post-MI infarcts identified 1,276 statistically different (all P < 0.05) genes (994 increased and 282 decreased in TG mice). Reduced expression of vascular endothelial growth factor A, platelet-derived growth factor subunit A, and transforming growth factor-β3, along with elevated expression of tissue inhibitor of MMP-4, in macrophages revealed mechanisms of indirect downstream effects on fibroblasts and neovascularization. While collagen accumulation was enhanced in TG mice compared with WT mice at days 0 and 7 post-MI ( P < 0.05 for both), the post-MI collagen cross-linking ratio was higher in WT mice ( P < 0.05), consistent with increased diastolic volumes. Vessel numbers [by Griffonia ( Bandeiraea) simplicifolia lectin I staining] were decreased in TG mice compared with WT mice at days 0 and 7 post-MI ( P < 0.05 for both). In conclusion, macrophage-derived MMP-9 improved post-MI cardiac wound healing through direct and indirect mechanisms to improve diastolic physiology and remodeling. NEW &amp; NOTEWORTHY Aging mice with macrophage overexpression of matrix metalloproteinase-9 have increased macrophage numbers 7 days after myocardial infarction, resulting in improved diastolic physiology and left ventricular remodeling through effects on cardiac wound healing.

Entities:  

Keywords:  RNA sequencing; angiogenesis; cardiac wound healing; collagen; left ventricular physiology

Mesh:

Substances:

Year:  2017        PMID: 29030341      PMCID: PMC5867652          DOI: 10.1152/ajpheart.00453.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  68 in total

1.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

2.  Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Nicolle L Patterson; Manishabrata Bhowmick; Elizabeth R Flynn; Majdouline Asher; Presley L Cannon; Kristine Y Deleon-Pennell; Gregg B Fields; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2016-10-13       Impact factor: 5.000

Review 3.  Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps.

Authors:  Yonggang Ma; Rugmani Padmanabhan Iyer; Mira Jung; Michael P Czubryt; Merry L Lindsey
Journal:  Trends Pharmacol Sci       Date:  2017-03-29       Impact factor: 14.819

4.  Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.

Authors:  Daniel R Wagner; Charles Delagardelle; Isabelle Ernens; Didier Rouy; Michel Vaillant; Jean Beissel
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

5.  Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Authors:  Hiroe Toba; Presley L Cannon; Andriy Yabluchanskiy; Rugmani Padmanabhan Iyer; Jeanine D'Armiento; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

6.  Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

Authors:  Mineo Iwata; Manoj Pillai; Aravind Ramakrishnan; Robert C Hackman; H Joachim Deeg; Ghislain Opdenakker; Beverly Torok-Storb
Journal:  Blood       Date:  2007-01-01       Impact factor: 22.113

7.  Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Fouad A Zouein; Yonggang Ma; Vincent Dive; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

8.  Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.

Authors:  José González-Santamaría; María Villalba; Oscar Busnadiego; Marina M López-Olañeta; Pilar Sandoval; Jessica Snabel; Manuel López-Cabrera; Janine T Erler; Roeland Hanemaaijer; Enrique Lara-Pezzi; Fernando Rodríguez-Pascual
Journal:  Cardiovasc Res       Date:  2015-08-10       Impact factor: 10.787

9.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

View more
  24 in total

Review 1.  Extracellular matrix in cardiovascular pathophysiology.

Authors:  Maria Bloksgaard; Merry Lindsey; Luis A Martinez-Lemus
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-21       Impact factor: 4.733

2.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

3.  Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction.

Authors:  Merry L Lindsey; Yonggang Ma; Elizabeth R Flynn; Michael D Winniford; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-20       Impact factor: 5.187

4.  Myeloid cells in cardiovascular organs.

Authors:  M Nahrendorf
Journal:  J Intern Med       Date:  2018-12-25       Impact factor: 8.989

5.  HDAC inhibition helps post-MI healing by modulating macrophage polarization.

Authors:  Denise Kimbrough; Sabina H Wang; Lillianne H Wright; Santhosh K Mani; Harinath Kasiganesan; Amanda C LaRue; Qi Cheng; Satish N Nadig; Carl Atkinson; Donald R Menick
Journal:  J Mol Cell Cardiol       Date:  2018-04-19       Impact factor: 5.000

6.  Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis.

Authors:  Li-Hao Huang; Bernd H Zinselmeyer; Chih-Hao Chang; Brian T Saunders; Andrew Elvington; Osamu Baba; Thomas J Broekelmann; Lina Qi; Joseph S Rueve; Melody A Swartz; Brian S Kim; Robert P Mecham; Helge Wiig; Michael J Thomas; Mary G Sorci-Thomas; Gwendalyn J Randolph
Journal:  Cell Metab       Date:  2018-11-08       Impact factor: 27.287

7.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.

Authors:  Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

8.  Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.

Authors:  Chris Watson; J Paul Spiers; Max Waterstone; Adam Russell-Hallinan; Joseph Gallagher; Kenneth McDonald; Cristin Ryan; John Gilmer; Mark Ledwidge
Journal:  BMC Cardiovasc Disord       Date:  2021-02-12       Impact factor: 2.298

Review 9.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

10.  The Mouse Heart Attack Research Tool 1.0 database.

Authors:  Kristine Y DeLeon-Pennell; Rugmani Padmanabhan Iyer; Yonggang Ma; Andriy Yabluchanskiy; Rogelio Zamilpa; Ying Ann Chiao; Presley L Cannon; Abdullah Kaplan; Courtney A Cates; Elizabeth R Flynn; Ganesh V Halade; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.